Safety: The Number I Flagged in June In June I called TRIUMPH-1s 11.3% discontinuation rate at 12 mg a number worth watching, and compared it to roughly 67% for tirzepatide 15 mg in SURMOUNT
It's the same with anti-obesity medications," she explained, adding that the drugs are not tested for people who do not have type 2 diabetes or chronic obesity
We provide science-backed treatments including GLP-1 injections and NuForm body sculpting technologies, all guided by experienced medical providers who prioritize safety, personalized care, and lasting results
Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, Pereira de Almeida L
Injectable BPC-157 is frequently discussed in preclinical models involving tissue biology, cellular signaling pathways, and broader systemic exposure
Semaglutide has demonstrated direct cardiovascular benefits independent of weight loss